HeartFlow
HeartFlow uses CT scans and computational fluid-dynamics modelling to assess blood flow in the coronary arteries, providing a non-invasive evaluation of coronary artery disease. The company listed publicly in 2025.
- Founded
- 2007
- Headquarters
- Mountain View, California, US
- Founders
- Charles Taylor, John Stevens
- Status
- Public (Nasdaq, 2025 IPO)
- Total funding
- ~$936M (pre-IPO)
- Latest round
- IPO (2025)
- Category
- Medical imaging AI
- Products
- HeartFlow FFRCT analysis, Plaque Analysis
- Website
- www.heartflow.com
Covered in: Artificial Intelligence in Healthcare
Profile compiled from the public sources listed above. Funding, valuation, and employee figures are point-in-time and may be out of date.